New guidelines from the Thrombosis

January 25, 2021
Avatar for Fast LabFast Lab

Introduction: Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and embolism (PE), is that the third commonest disorder and, globally, quite an estimated 10 million people have it yearly. it’s a chronic and recurrent disease. The symptoms of VTE are non‐specific and therefore the diagnosis should actively be sought once considered. The mainstay of VTE treatment is anticoagulation, with few patients requiring additional intervention.

A working party of experts within the area recently completed an evidence‐based guideline for the diagnosis and management of DVT and PE on behalf of the Thrombosis and Haemostasis Society of Australia and New Zealand

Main recommendations:

  • The diagnosis of VTE should be established with imaging; it’s going to be excluded by the utilization of clinical prediction rules combined with D‐dimer testing.
  • Proximal DVT or PE caused by a major surgery or trauma that is no longer present should be treated with anticoagulant therapy for 3 months.
  • Proximal DVT or PE caused by a serious surgery or trauma that’s not present should be treated with anticoagulant therapy for 3 months.
  • Proximal DVT or PE that is recurrent (two or more) and provoked by active cancer or antiphospholipid syndrome should receive extended anticoagulation.

Changes in management as a results of the guideline: Most patients with acute VTE should be treated with an element Xa inhibitor and be assessed for extended anticoagulation.

Leave a comment